Ketones

6-Fluoro-5-Methyl-2-[(5-Methyl-1H-Imidazol-4-Yl)Methyl]-2,3,4,5-Tetrahydro-1H-Pyrido[4,3-b]Indol-1-One is a drug that belongs to the class of fatty acid esters. It has been shown to be effective in clinical trials for the treatment of symptoms of dry eye syndrome. 6FMETI has a low safety profile and does not cause any adverse effects in humans. The drug can be administered by intravenous injection or oral administration and has a long elimination half life of 36 hours. 6FMETI is metabolized by hydrolysis to its active form, 5FMTI, which is then conjugated with glucuronic acid or methyl glutaryl coenzyme A to form an inactive metabolite. This drug also has good pharmacokinetic properties

5-Phenyl-7-(Trifluoromethyl)-1,3-Dihydro-1,4-Benzodiazepin-2-One is a pyrethroid that has been shown to have an effective dose of 10 μg/kg in pharmacological tests. It has been shown to modulate hydrogen bond formation and the hydrophobic effects of diazepam. 5-Phenyl-7-(Trifluoromethyl)-1,3-Dihydro-1,4-Benzodiazepin-2-One is a monomer that can be used for the treatment of cancer. This active compound has been found to bind to the benzodiazepine binding site on GABA receptors in the brain and has been shown to induce digitonin release from nerve endings. It also binds with carbonyl groups which are found on proteins and nucleic acids.

4-Fluoroandrostenedione is a synthetic, nonsteroidal compound that has been shown to be an effective androgen ablation agent. It binds to the androgen receptor, which prevents conversion of testosterone into dihydrotestosterone (DHT). 4-Fluoroandrostenedione has been used in clinical trials for the treatment of prostate cancer. This drug has also been shown to inhibit the production of estrogens by binding to the aromatase enzyme, which converts androgens into estrogens. Substitutions on the a-ring have been shown to increase its activity as an anti-cancer agent. 4-Fluoroandrostenedione can be synthesized from androstenedione by substituting a fluorine atom on one of the carbons in the a-ring.

9-Fluoro-17beta-Hydroxy-17-Methyl-5β-Androstane-3,11-Dione is a chemical compound that has oxidizing properties. It is a white or light yellow crystalline powder that can be prepared from potassium and 9-fluoroandrostenedione. The compound is insoluble in water, but soluble in organic solvents. It has a melting point of about 138°C, and does not react with alkali metals or bases. 9FAD has been shown to have thermal treatment applications for the fields of pulverulent materials and input introduction. Thermally applied, it can be used to increase the surface area of input materials such as coal and ore, as well as being able to convert them into more reactive forms.

Benzenesulphonylacetone is an organic solvent with antihypertensive activity. It has been shown in vitro to inhibit the protein kinase, b-raf, and to have antioxidant properties. Benzenesulphonylacetone has been shown to be a competitive inhibitor of the alkoxy radical and the active methylene group, both of which are necessary for the production of asymmetric synthesis. The synthesis of benzenesulphonylacetone can be achieved by reacting methyl sulfones with activated chloride under high pressure and temperature. This process also results in the formation of 2-bromo-3-nitrobenzoic acid, which is then reacted with alkylthio groups to produce benzenesulphonylacetone. Its peptidomimetic form was developed through nitro substitution at position 3 on the benzene ring.

2-Iodophenyl)(2,3,6,7-tetrahydro-1H,5H-benzo[ij]quinolizin-9-yl)methanone is a high quality reagent that can be used as a useful intermediate and building block in the synthesis of complex compounds.

2-Aminothiophen-3-yl)(4-bromophenyl)methanone is a new compound that is being developed as a potential antiviral agent. Covid-19, the trade name for 2-aminothiophen-3-yl)(4-bromophenyl)methanone, prevents the replication of viruses by binding to their nucleic acids and blocking their ability to produce proteins. Covid-19 has been shown to be effective against both influenza A and B viruses in cellular and animal models. The antiviral activity of Covid-19 is due to its ability to bind to viral nucleic acid, preventing the production of proteins vital for viral replication. This compound has also been shown to have anti-inflammatory properties, which may be due to its ability to inhibit the production of amyloid plaques in mice with Alzheimer's disease.